Abstract
Staphylococcus aureus (S. aureus) is a known trigger and cause of infectious complications in atopic dermatitis (AD). Various antiseptics have been used in an attempt to decrease the burden of S. aureus in AD. In this Commentary, we present the evidence for and against some of the commonly-used antiseptics in clinical and research settings. These agents remain attractive as an adjunct therapy for AD due to their relative low cost and potential benefits of reducing S. aureus. Though a number of studies have evaluated the use of dilute bleach, its mechanisms remain controversial. A higher concentration of bleach than the commonly-used 0.005% is likely needed for its anti-S. aureus effect. Silver-coated textiles have demonstrated anti-S. aureus effects in various studies, however, their efficacy and side effects in AD remain to be confirmed. Other antiseptics including chlorhexidine, triclosan and triclocarban are also discussed. Variables that may affect the outcomes of these studies include length of use, concurrent application of moisturizers and anti-inflammatory medications.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
